Skip to main content
. 2017 Jul 11;7(3):598–608. doi: 10.1177/2045893217719250

Fig. 1.

Fig. 1.

Balancing PAH symptoms versus prostacyclin pathway therapy side effects. PAH, pulmonary arterial hypertension.